Skip to main content
Previous Poster Home Next

Neoadjuvant Tyrosine Kinase Inhibitors (TKIs) Efficacy in EGFR Positive Stage III Nonsmall Cell Lung Cancer (NSCLC): A Systematic Review and Meta-Analysis
07:30am - 03:35pm EST - April 6, 2024

  • Information
  • Resources
  • Play Recording

Neoadjuvant Tyrosine Kinase Inhibitors (TKIs) Efficacy in EGFR Positive Stage III Nonsmall Cell Lung Cancer (NSCLC): A Systematic Review and Meta-Analysis icon

Abstract: JNCCN23-0778 https://jnccn.org/view/journal...


Author(s):
  • John Kelvin Lalusis, MD, Medica Oncology Fellow, Saint Luke's Medical Center Philippines

Tags: Clinical Oncology

Display Label Action
AC24P134 - Neoadjuvant Tyrosine Kinase Inhibitors (TKIs) Efficacy in EGFR Positive Stage III Nonsmall Cell Lung Cancer (NSCLC): A Systematic Review and Meta-Analysis Download MP3